Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicholas A Butowski Susan Soon Mee Chang Lisa M DeAngelis Lauren E Abrey Michael D Prados Minesh Mehta |
| Publication date | March 3, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |